A 60-year-old man with COPD is maintained on inhaled corticosteroid (ICS) monotherapy. He has had two pneumonias in the past year and continues to be ...

Question

A 60-year-old man with COPD is maintained on inhaled corticosteroid (ICS) monotherapy. He has had two pneumonias in the past year and continues to be dyspnoeic with exertion. According to the Canadian Thoracic Society COPD pharmacotherapy guideline, what is the best change to his inhaled regimen?

Accepted Answer

Switch to LAMA/LABA dual therapy and discontinue ICS

Answer

Continue ICS monotherapy but increase the dose

Answer

Stop ICS and start long-acting muscarinic antagonist (LAMA) monotherapy

Answer

Add a long-acting beta₂-agonist (LABA) to his ICS to create ICS/LABA therapy

Answer

Add chronic oral prednisone while continuing ICS

ca-mccqe1 MCQ (SBA): Chronic obstructive pulmonary disease

A 60-year-old man with COPD is maintained on inhaled corticosteroid (ICS) monotherapy. He has had two pneumonias in the past year and continues to be dyspnoeic with exertion. According to the Canadian Thoracic Society COPD pharmacotherapy guideline, what is the best change to his inhaled regimen?